Tazidime and Fluid retention - a phase IV clinical study of FDA data

Summary:

Fluid retention is reported as a side effect among people who take Tazidime (ceftazidime), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Fluconazole, and have Mucosal inflammation.

The phase IV clinical study analyzes which people have Fluid retention when taking Tazidime. It is created by eHealthMe based on reports of 10,389 people who have side effects when taking Tazidime from the FDA, and is updated regularly.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.

What is Fluid retention?

Fluid retention (an abnormal accumulation of fluid in the blood) is found to be associated with 1,699 drugs and 2,448 conditions by eHealthMe. Check the latest studies of Fluid retention.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 13, 2026

10,389 people reported to have side effects when taking Tazidime.
Among them, 15 people (0.14%) have Fluid retention.

Among these 15 people:

How long have people been on Tazidime when they have Fluid retention? *

What is the gender of people who have Fluid retention when taking Tazidime? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Fluid retention when taking Tazidime? *

What are other drugs people take besides Tazidime? *

What are other side effects people have besides Fluid retention? *

Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 6 people, 40.00%
Pneumonia: 6 people, 40.00%
Mucosal Inflammation (infection of mucous membrane): 5 people, 33.33%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 5 people, 33.33%
Weight Increased: 5 people, 33.33%
Lung Injury: 4 people, 26.67%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 4 people, 26.67%
Pleural Effusion (water on the lungs): 4 people, 26.67%
Capillary Leak Syndrome (capillary leaks plasma): 4 people, 26.67%
Clostridial Infection (infectious conditions by clostridium bacteria): 4 people, 26.67%

What are the existing conditions these people have? *

Mucosal Inflammation (infection of mucous membrane): 4 people, 26.67%
Pneumonia: 1 person, 6.67%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 6.67%
High Blood Pressure: 1 person, 6.67%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 1 person, 6.67%
Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 1 person, 6.67%
Cellulitis (infection under the skin): 1 person, 6.67%
Bone Disorder: 1 person, 6.67%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Tazidime and have Fluid retention?

- Check whether Fluid retention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tazidime:

Tazidime (10,409 reports)

Fluid retention treatments and more:

Fluid retention (79,660 reports)

Browse all side effects of Tazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fluid retention:

Fluid retention (1,699 drugs)

Browse all the conditions that are associated with Fluid retention:

Fluid retention (2,448 conditions)

Related publications that referenced our studies

Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime (the active ingredients of Tazidime) and Tazidime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.